Cold Application on the Subcutaneous Injection (NCT05771285) | Clinical Trial Compass
CompletedNot Applicable
Cold Application on the Subcutaneous Injection
78 participantsStarted 2017-01
Plain-language summary
The goal of this clinical trial is to compare the effect of cold application at different periods of time on the occurrence of bruising, haematoma and pain in the subcutaneous low molecular weight heparin (LMWH) injected patients.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* to receive LMWH (pre-filled syringe containing 40 mg enoxaparin sodium in 0.4 ml) treatment at least once a day
* not to have any visual or auditory disorders
* not to have any foreknown coagulation disorders
* to have platelet, PTT and international normalized ratio (INR) values within the normal limits for beginning enoxaparin sodium injections
* not to have any hematologic disorders or any bruising or injuries at the abdominal wall
* to receive no injections at the abdominal site, other than the enoxaparin sodium during the research protocol
* to will to participate in this study
Exclusion Criteria:
* to be pregnant
* have bleeding in the injection site
* have pain at any site of their body prior to the injection
* have any incision, drain, scar tissue, lipodystrophy or infection symptoms at the abdominal site which hinder the application of injection
* not to will to participate in this study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Compare of the bruise occurrence change at 48th and 72nd hours after the heparin injection.
Timeframe: after 48th and 72nd hours from injection
2
Compare of the bruise sizes change of the patients at 48th and 72nd hours.
Timeframe: after 48th and 72nd hours from injection
3
Compare of the Visual Analogue Scale pain scores of the patients
Timeframe: after 1 minute from injection administration